{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:56:15Z","timestamp":1784141775699,"version":"3.55.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00489","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T07:30:24Z","timestamp":1557300624000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Respiratory Fluoroquinolones Monotherapy vs. \u03b2-Lactams With or Without Macrolides for Hospitalized Community-Acquired Pneumonia Patients: A Meta-Analysis"],"prefix":"10.3389","volume":"10","author":[{"given":"Sitong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"18","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1111\/crj.12674","article-title":"Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines","volume":"12","author":"Cao","year":"2018","journal-title":"Clin. Respir. J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3969\/j.issn.0253-9713.2006.12.021","article-title":"Observation of curative effect of levofloxacin on community-acquired pneumonia (Chinese)","volume":"28","author":"Chang","year":"2006","journal-title":"Beijing Med. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10096-003-1060-x","article-title":"Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia","volume":"23","author":"Erard","year":"2004","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1128\/AAC.46.6.1746-1754.2002","article-title":"Randomized controlled trial of sequential intravenous (iv) and oral moxifloxacin compared with sequential iv and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment","volume":"46","author":"Finch","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1021\/cr030102i","article-title":"Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity","volume":"105","author":"Fisher","year":"2005","journal-title":"Chem. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/S0149-2918(02)80034-0","article-title":"A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia","volume":"24","author":"Frank","year":"2002","journal-title":"Clin. Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.3321\/j.issn:1005-4529.2009.22.041","article-title":"Comparison of moxifloxacin and cefuroxime combined with azithromycin for patients with community-acquired pneumonia (Chinese)","volume":"19","author":"Gao","year":"2009","journal-title":"Chin. J. Nosocomiol."},{"key":"B9","unstructured":"HanB.\n            NingX. C.\n            ChaiW. S.\n          Clinical observation of moxifloxacin versus ceftriaxone combined with azithromycin in the treatment (Chinese). Chin. Pharm. 21, 3400\u201334012010"},{"key":"B10","unstructured":"HigginsJ.\n            AltmanD.\n          Chapter 8:Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration"},{"key":"B11","unstructured":"HigginsJ.\n            AltmanD. E.\n          Chapter 7:Selecting studies and collecting data. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1378\/chest.09-0285","article-title":"Antibiotic resistance in community-acquired pneumonia caused by Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Acinetobacter baumannii","volume":"136","author":"Ho","year":"2009","journal-title":"Chest"},{"key":"B13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3201\/eid0702.010239","article-title":"Emerging mechanisms of fluoroquinolone resistance","volume":"7","author":"Hooper","year":"2001","journal-title":"Emerg. Infect. Dis"},{"key":"B14","unstructured":"HuangG.\n            JiangY. Y.\n            ZhouY. J.\n            LingX. J.\n            QiuT. F.\n            ZhouY.\n          Sequential moxifloxacin therapy in the treatment of elderly patients with community-acquired pnuemonia: clinical evaluation (Chinese). J. Nanjing Med. Nat. Sci. 28, 1457\u201314602008"},{"key":"B15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/BF03261911","article-title":"High-dose levofloxacin in community-acquired pneumonia","volume":"32","author":"Lee","year":"2012","journal-title":"Clin. Drug Invest"},{"key":"B16","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.rmed.2004.04.007","article-title":"Gemifloxacin once daily for 7 days compared to amoxicillin\/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin","volume":"98","author":"Leophonte","year":"2004","journal-title":"Respir. Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3969\/j.issn.1007-9572.2009.16.027","article-title":"A comparison between levofloxacin and cefuroxime with azithromycin in community-acquired pneumonia (Chinese)","volume":"12","author":"Li","year":"2009","journal-title":"Chin. Gen. Pract"},{"key":"B18","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1136\/thx.2009.121434","article-title":"BTS guidelines for the management of community acquired pneumonia in adults: update 2009","volume":"64","author":"Lim","year":"2009","journal-title":"Thorax."},{"key":"B19","first-page":"321","article-title":"An open-label, randomized comparison of levofloxacin and amoxicillin\/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia","volume":"30","author":"Lin","year":"2007","journal-title":"Chang. Gung Med. J"},{"key":"B20","unstructured":"LiuL. Y.\n            XiaoY. H.\n            YanP. K.\n            XuJ.\n            GuanB. E.\n          Efficacy of moxifloxacin vs. azithromycin plus cefoperazone\/sulbactam for community acquired pneumonia (Chinese). Eval. Anal. Drug Use Hosp. China. 12, 543-5452012"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0149-2918(02)80088-1","article-title":"Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone\/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability","volume":"24","author":"Lode","year":"2002","journal-title":"Clin. Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious diseases society of america\/american thoracic society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin. Infect. Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jiac.2015.12.019","article-title":"JAID\/JSC guidelines for the treatment of respiratory infectious diseases: the japanese association for infectious Diseases\/Japanese society of chemotherapy - The JAID\/JSC guide to clinical management of infectious Disease\/Guideline-preparing committee respiratory infectious disease WG","volume":"22","author":"Mikasa","year":"2016","journal-title":"J. Infect. Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1056\/NEJMra1312885","article-title":"Community-acquired pneumonia","volume":"371","author":"Musher","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10096-005-1347-1","article-title":"Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors","volume":"24","author":"Portier","year":"2005","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1056\/NEJMoa1406330","article-title":"Antibiotic treatment strategies for community-acquired pneumonia in adults","volume":"372","author":"Postma","year":"2015","journal-title":"N. Engl. J. Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1502","article-title":"Telithromycin","author":"Raja","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"B28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3321\/j.issn:1009-7708.2008.02.005","article-title":"A randomized controlled multicentre clinical trial of levofloxacin sequential therapy compared with combination therapy with cefuroxime and azithromycin in patients with community-acquired pneumonia (Chinese)","volume":"8","author":"Shao","year":"2008","journal-title":"Chin. J. Infect. Chemother"},{"key":"B29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/cid\/cix773","article-title":"Antibiotic expenditures by medication, class, and healthcare setting in the united states, 2010-2015","volume":"6","author":"Suda","year":"2018","journal-title":"Clin Infect Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0022-2836(03)00662-4","article-title":"The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome","volume":"25","author":"Tenson","year":"2003","journal-title":"J. Mol. Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1378\/chest.11-1160","article-title":"Incidence and cost of pneumonia in medicare beneficiaries","volume":"142","author":"Thomas","year":"2012","journal-title":"Chest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1503\/cmaj.080358","article-title":"Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials","volume":"179","author":"Vardakas","year":"2008","journal-title":"CMAJ"},{"key":"B33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrmicro727","article-title":"Where will new antibiotics come from?","volume":"1","author":"Walsh","year":"2003","journal-title":"Nat. Rev. Microbiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1086\/498149","article-title":"Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy","volume":"41","author":"Welte","year":"2005","journal-title":"Clin. Infect. Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/thx.2009.129502","article-title":"Clinical and economic burden of community-acquired pneumonia among adults in Europe","volume":"67","author":"Welte","year":"2012","journal-title":"Thorax"},{"key":"B36","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections\u2013full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin. Microbiol. Infect"},{"key":"B37","doi-asserted-by":"publisher","first-page":"844","DOI":"10.13699\/j.cnki.1001-6821.2014.09.030","article-title":"Guidance for clinical trials of anti- bacterial drugs (Chinese)","volume":"30","year":"2014","journal-title":"Chin. J. Clin. Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11596-006-0411-0","article-title":"Efficacy and safety of intravenous moxifloxacin versus cefoperazone with azithromycin in the treatment of community acquired pneumonia","volume":"26","author":"Xu","year":"2006","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci"},{"key":"B39","unstructured":"YangS. G.\n            ZhangS. H.\n          Efficacy and cost-effectiveness analysis of moxifloxacin hydrochloride and combination of ceftriaxone sodium with azithromycin in the treatment of moderate to severe community acquired pneumonia in elderly patients (Chinese). Chin. J. New. Drugs 28, 962\u20139642009"},{"key":"B40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2165\/00151829-200403050-00006","article-title":"Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia","volume":"3","author":"Zervos","year":"2004","journal-title":"Treat. Respir. Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3760\/cma.j.issn.1673-436X.2006.04.002","article-title":"Multicentre clinical study on levofloxacin intravenous injection for treatment of community-acquired pneumonia (Chinese)","volume":"26","author":"Zhang","year":"2006","journal-title":"Int. J. Respir"},{"key":"B42","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3321\/j.issn:1005-4529.2007.05.045","article-title":"Comparison of levofloxacin alone and cefuroxime combined with azithromycin for patients with community-acquired pneumonia (Chinese)","volume":"17","author":"Zhao","year":"2007","journal-title":"Chin. J. Nosocomiol"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00489\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T07:30:34Z","timestamp":1557300634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00489\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":42,"alternative-id":["10.3389\/fphar.2019.00489"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00489","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"article-number":"489"}}